Crossmark

The prevalence of mild cognitive impairment in breast cancer patients receiving chemotherapy according to the criteria of the National Institute on Aging-Alzheimer’s Association (NIA-AA)

Crossref DOI link: https://doi.org/10.1007/s11764-024-01608-0

Published Online: 2024-04-26

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Albers, E. A. C.

Kieffer, J. M.

Schagen, S. B.
License Information

Text and Data Mining valid from 2024-04-26

Version of Record valid from 2024-04-26
More Information

Article History

Received: 11 March 2024

Accepted: 18 April 2024

First Online: 26 April 2024

Declarations

:

: This study was approved by the local Institutional Review Board of the Dutch Cancer Institute.

: Informed consent was obtained from all individual participants included in this study.

: The authors affirm that all human research participants provided informed consent for publication of their data.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below